Read + Share
Amedeo Smart
Independent Medical Education
Nyquist OE, Dalgaard J, Spetalen S, Torkildsen S, et al. Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML. Br J Haematol 2024;204:724-729.PMID: 38016923
Email
LinkedIn
Facebook
Twitter
Privacy Policy